Ding Y - Search Results

1

Interferon-inducible protein IFIXalpha inhibits cell invasion by upregulating the metastasis suppressor maspin.

Yamaguchi H, Ding Y, Lee JF, Zhang M, Pal A, Bornmann W, Yan DH, Hung MC. Yamaguchi H, et al. Among authors: ding y. Mol Carcinog. 2008 Oct;47(10):739-43. doi: 10.1002/mc.20423. Mol Carcinog. 2008. PMID: 18247378 Free PMC article.

2

Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2.

Ding Y, Lee JF, Lu H, Lee MH, Yan DH. Ding Y, et al. Mol Cell Biol. 2006 Mar;26(5):1979-96. doi: 10.1128/MCB.26.5.1979-1996.2006. Mol Cell Biol. 2006. PMID: 16479015 Free PMC article.

3

Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.

Ding Y, Wen Y, Spohn B, Wang L, Xia W, Kwong KY, Shao R, Li Z, Hortobagyi GN, Hung MC, Yan DH. Ding Y, et al. Clin Cancer Res. 2002 Oct;8(10):3290-7. Clin Cancer Res. 2002. PMID: 12374701

4

P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells.

Yan DH, Abramian A, Li Z, Ding Y, Wen Y, Liu TJ, Hunt K. Yan DH, et al. Among authors: ding y. Biochem Biophys Res Commun. 2003 Mar 28;303(1):219-22. doi: 10.1016/s0006-291x(03)00320-6. Biochem Biophys Res Commun. 2003. PMID: 12646190

5

Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer.

Ding Y, Wang L, Su LK, Frey JA, Shao R, Hunt KK, Yan DH. Ding Y, et al. Oncogene. 2004 Jun 3;23(26):4556-66. doi: 10.1038/sj.onc.1207592. Oncogene. 2004. PMID: 15122330

6

p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models.

Wen Y, Yan DH, Wang B, Spohn B, Ding Y, Shao R, Zou Y, Xie K, Hung MC. Wen Y, et al. Among authors: ding y. Cancer Res. 2001 Oct 1;61(19):7142-7. Cancer Res. 2001. PMID: 11585747

7

E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation.

Shao R, Lee DF, Wen Y, Ding Y, Xia W, Ping B, Yagita H, Spohn B, Hung MC. Shao R, et al. Among authors: ding y. Mol Cancer Res. 2005 Apr;3(4):219-26. doi: 10.1158/1541-7786.MCR-04-0084. Mol Cancer Res. 2005. PMID: 15831675

8

Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.

Ayala G, Yan J, Li R, Ding Y, Thompson TC, Mims MP, Hayes TG, MacDonnell V, Lynch RG, Frolov A, Miles BJ, Wheeler TM, Harper JW, Tsai MJ, Ittmann MM, Kadmon D. Ayala G, et al. Among authors: ding y. Clin Cancer Res. 2008 Nov 15;14(22):7511-8. doi: 10.1158/1078-0432.CCR-08-0839. Clin Cancer Res. 2008. PMID: 19010869 Free PMC article. Clinical Trial.

9

Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer.

Ding Y, He D, Florentin D, Frolov A, Hilsenbeck S, Ittmann M, Kadmon D, Miles B, Rowley D, Ayala G. Ding Y, et al. Clin Cancer Res. 2013 Nov 15;19(22):6101-11. doi: 10.1158/1078-0432.CCR-12-3669. Epub 2013 Oct 4. Clin Cancer Res. 2013. PMID: 24097862 Free PMC article.

10

Neuronal Trans-Differentiation in Prostate Cancer Cells.

Farach A, Ding Y, Lee M, Creighton C, Delk NA, Ittmann M, Miles B, Rowley D, Farach-Carson MC, Ayala GE. Farach A, et al. Among authors: ding y. Prostate. 2016 Oct;76(14):1312-25. doi: 10.1002/pros.23221. Epub 2016 Jul 12. Prostate. 2016. PMID: 27403603 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,564 results

Search Page

Filters